+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Botulinum Toxins Market Research Report by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5337538
  • Report
  • July 2021
  • Region: Global
  • 197 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Botulinum Toxins Market will Grow to USD 7,587.03 Million by 2026, at a CAGR of 15.29%

FEATURED COMPANIES

  • AbbVie Inc.
  • Galderma S.A.
  • Hugel, Inc
  • JUVAPLUS
  • Medytox Inc.
  • Object Pharma, Inc.
The Global Botulinum Toxins Market size was estimated at USD 3,230.60 Million in 2020 and expected to reach USD 3,713.68 Million in 2021, at a Compound Annual Growth Rate (CAGR) 15.29% to reach USD 7,587.03 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Botulinum Toxins to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Application, the Botulinum Toxins Market was studied across Aesthetic and Therapeutic.
  • Based on Type, the Botulinum Toxins Market was studied across AbobotulinumtoxinA, IncobotulinumtoxinA, OnabotulinumtoxinA, and RimabotulinumtoxinB.
  • Based on Region, the Botulinum Toxins Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Botulinum Toxins Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Botulinum Toxins Market, including AbbVie Inc., Ajinomoto Bio-Pharma Services, Bausch Health Companies Inc., Daewoong Pharmaceuticals Co.Ltd., Eisai Co., Ltd, Galderma S.A., Gufic Biosciences Ltd., Hugel, Inc, Hugh Source International Ltd., Ipsen group, JUVAPLUS, Lanzhou Institute of Biological Products Co. Ltd., List Biological Labs, Inc, Medytox Inc., Merz GmbH & Co. KGaA, Object Pharma, Inc., Pfizer Inc., Revance Therapeutics, Inc., Shanghai Haohai Biological Technology Co., Ltd., and US Worldmeds, LLC.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Botulinum Toxins Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Botulinum Toxins Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Botulinum Toxins Market?
4. What is the competitive strategic window for opportunities in the Global Botulinum Toxins Market?
5. What are the technology trends and regulatory frameworks in the Global Botulinum Toxins Market?
6. What is the market share of the leading vendors in the Global Botulinum Toxins Market?
7. What modes and strategic moves are considered suitable for entering the Global Botulinum Toxins Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Galderma S.A.
  • Hugel, Inc
  • JUVAPLUS
  • Medytox Inc.
  • Object Pharma, Inc.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. Region Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of non-invasive cosmetic procedures
5.1.1.2. Increasing individuals highly conscious of their appearance
5.1.1.3. Rising aging population demand for procedures to make their skin look young
5.1.2. Restraints
5.1.2.1. Relatively high cost of the procedure
5.1.3. Opportunities
5.1.3.1. Increasing number of product approvals and launch of novel products
5.1.3.2. Surging awareness of therapeutic and cosmetic application of botulinum toxin
5.1.4. Challenges
5.1.4.1. Probable side effects of the procedure
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Botulinum Toxins Market, by Application
6.1. Introduction
6.2. Aesthetic
6.3. Therapeutic

7. Botulinum Toxins Market, by Type
7.1. Introduction
7.2. AbobotulinumtoxinA
7.3. IncobotulinumtoxinA
7.4. OnabotulinumtoxinA
7.5. RimabotulinumtoxinB

8. Americas Botulinum Toxins Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Botulinum Toxins Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Botulinum Toxins Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. AbbVie Inc.
12.2. Ajinomoto Bio-Pharma Services
12.3. Bausch Health Companies Inc.
12.4. Daewoong Pharmaceuticals Co.Ltd.
12.5. Eisai Co., Ltd
12.6. Galderma S.A.
12.7. Gufic Biosciences Ltd.
12.8. Hugel, Inc
12.9. Hugh Source International Ltd.
12.10. Ipsen group
12.11. JUVAPLUS
12.12. Lanzhou Institute of Biological Products Co. Ltd.
12.13. List Biological Labs, Inc
12.14. Medytox Inc.
12.15. Merz GmbH & Co. KGaA
12.16. Object Pharma, Inc.
12.17. Pfizer Inc.
12.18. Revance Therapeutics, Inc.
12.19. Shanghai Haohai Biological Technology Co., Ltd.
12.20. US Worldmeds, LLC

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL BOTULINUM TOXINS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 3. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 4. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 5. GLOBAL BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL BOTULINUM TOXINS MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL BOTULINUM TOXINS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 9. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2026
FIGURE 11. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 16. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2026
FIGURE 18. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY ABOBOTULINUMTOXINA, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY ABOBOTULINUMTOXINA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY INCOBOTULINUMTOXINA, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY INCOBOTULINUMTOXINA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY ONABOTULINUMTOXINA, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY ONABOTULINUMTOXINA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY RIMABOTULINUMTOXINB, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY RIMABOTULINUMTOXINB, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. AMERICAS BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 27. ARGENTINA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 28. BRAZIL BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 29. CANADA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. MEXICO BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. UNITED STATES BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. CHINA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. INDIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. INDONESIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. JAPAN BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. MALAYSIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. SINGAPORE BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. THAILAND BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. FRANCE BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. GERMANY BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. ITALY BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. QATAR BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. RUSSIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. SPAIN BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. GLOBAL BOTULINUM TOXINS MARKET: FPNV POSITIONING MATRIX
FIGURE 56. GLOBAL BOTULINUM TOXINS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 57. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BOTULINUM TOXINS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL BOTULINUM TOXINS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY AESTHETIC, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY ABOBOTULINUMTOXINA, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY INCOBOTULINUMTOXINA, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY ONABOTULINUMTOXINA, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL BOTULINUM TOXINS MARKET SIZE, BY RIMABOTULINUMTOXINB, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. AMERICAS BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 13. ARGENTINA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 14. BRAZIL BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. CANADA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. MEXICO BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. ASIA-PACIFIC BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. AUSTRALIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. CHINA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. INDIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. INDONESIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. JAPAN BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. MALAYSIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. PHILIPPINES BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. SINGAPORE BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. SOUTH KOREA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. THAILAND BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. FRANCE BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. GERMANY BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. ITALY BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. NETHERLANDS BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. QATAR BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. RUSSIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. SAUDI ARABIA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. SOUTH AFRICA BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SPAIN BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. UNITED ARAB EMIRATES BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. UNITED KINGDOM BOTULINUM TOXINS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. GLOBAL BOTULINUM TOXINS MARKET: SCORES
TABLE 42. GLOBAL BOTULINUM TOXINS MARKET: BUSINESS STRATEGY
TABLE 43. GLOBAL BOTULINUM TOXINS MARKET: PRODUCT SATISFACTION
TABLE 44. GLOBAL BOTULINUM TOXINS MARKET: RANKING
TABLE 45. GLOBAL BOTULINUM TOXINS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 46. GLOBAL BOTULINUM TOXINS MARKET: MERGER & ACQUISITION
TABLE 47. GLOBAL BOTULINUM TOXINS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 48. GLOBAL BOTULINUM TOXINS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 49. GLOBAL BOTULINUM TOXINS MARKET: INVESTMENT & FUNDING
TABLE 50. GLOBAL BOTULINUM TOXINS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 51. GLOBAL BOTULINUM TOXINS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Ajinomoto Bio-Pharma Services
  • Bausch Health Companies Inc.
  • Daewoong Pharmaceuticals Co.Ltd.
  • Eisai Co., Ltd
  • Galderma S.A.
  • Gufic Biosciences Ltd.
  • Hugel, Inc
  • Hugh Source International Ltd.
  • Ipsen group
  • JUVAPLUS
  • Lanzhou Institute of Biological Products Co. Ltd.
  • List Biological Labs, Inc
  • Medytox Inc.
  • Merz GmbH & Co. KGaA
  • Object Pharma, Inc.
  • Pfizer Inc.
  • Revance Therapeutics, Inc.
  • Shanghai Haohai Biological Technology Co., Ltd.
  • US Worldmeds, LLC
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll